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Abstract 
 
 
ASSESSING FEASIBILITY AND EFFECTIVENESS OF PEDIATRIC DENTAL 
PROVIDER’S ROLE IN ORAL HEALTH AND PREVENTION EDUCATION IN THE CARE 
OF CHILDREN WITH LEUKEMIA 
By: Hannah Rustin, DMD 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science 
in Dentistry at Virginia Commonwealth University. 
Virginia Commonwealth University, 2018 
Thesis Advisors:  
William Dahlke, DMD 
Associate Professor, Chair of Department of Pediatric Dentistry 
Frances Austin, MD 
Assistant Professor, Department of Pediatrics, Division of Hematology Oncology 
Purpose: Pediatric dentists could serve a role in care of children with leukemia. Oral sequelae of 
cancer therapies are well documented. The purpose of this study is to assess the feasibility and 
effectiveness of the pediatric dentist in the care of patients with leukemia. 
Methods: Pediatric Hematology and Oncology at Virginia Commonwealth University was 
educated on the proposed protocol and administered a questionnaire to assess feasibility of 
implementing prevention education by the pediatric dentist. Patients were randomized into two 
groups at diagnosis: one receiving current oral health protocol and those receiving one-on-one 
prevention education with the pediatric dentist at three points during treatment. Data was 
collected through clinical intraoral examination and salivary sample.  
Results: All respondents reported this would address a known problem for patients. They agreed 
it is feasible and would be a valuable addition to care of these patients. Subject recruitment is 
ongoing for the effectiveness portion of the study. 
Conclusion: The addition of the pediatric dentist to the pediatric oncology care team is warranted 
and feasible. 
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Introduction 
 
 
Leukemia is the most common pediatric malignancy, accounting for approximately 30% 
of cancers diagnosed in children under the age of 15.1,2 Acute lymphoblastic leukemia (ALL) is 
most common pediatric leukemia; accounting for 75%of all new leukemia diagnoses and 25% of 
malignancies in childhood.2,3 Most other cases are acute myeloid leukemia.  Leukemia is 
characterized by uncontrolled reproduction of hematopoietic stem cells in the bone marrow and 
then diffusion of these cells into peripheral blood.4 The highest incidence of leukemia in children 
is between 2 and 5 years of age.2 Pediatric patients undergo extensive courses of therapy lasting 
2 to 3 years, which has increased survival rates. Pediatric patients experience many well-
identified acute oral sequelae during treatment for leukemia, and survivors continue to be at risk 
for dental abnormalities and complications associated with chemotherapy.5 
There are multiple identified oral manifestations that can be attributed to the malignancy 
or secondary to cancer therapies. Hong et al reported a mean incidence of 54% of children 
experiencing acute oral sequelae, with varying percentages between 31-93% reported by others.6 
Oral mucositis is a commonly reported painful complication resulting from the cytotoxic effects 
of cancer therapies on epithelial and subepithelial tissues.1,2,7 The lesions first present as an 
erythematous plaque and progress to ulcerations.2 Gingivitis was noted more often in one study 
in children with ALL than healthy children in the control group. 3 Gingivitis was the most 
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common oral manifestation, affecting over 90%of patients undergoing therapy for ALL in a 
study by Ponce-Torres et al.7 Oral petechiae has been observed in 32% of patients.6 Oral mucosal 
infections due to various organisms have also been reported. 1,2,7,8A 2009 literature review 
reported the mean incidence of oral candidiasis to be 15%. The reported incidence of herpes 
simplex virus infections was 8%, pseudomonas infection of lips was 4 percent, and necrotizing 
ulcerative gingivitis was 2%. 6 Xerostomia is also commonly reported. 1,2,7,8 
Pediatric oncology patients are also at an increased risk for systemic infections due to 
immunosuppression. It has been reported that 25-54% of incidences of septicemia in patients 
being treated for cancer with neutropenia seem to originate from bacteria that colonize the oral 
cavity.9 Elad et al concluded that dental treatment preceding chemotherapy is supported for 
reduction of disseminated infections during subsequent periods of immunosuppression.  Based 
on data analysis in this study, foregoing dental treatment prior to the initiation of chemotherapy 
increased the probability of mortality due to odontogenic infection for an additional 1.8 of every 
1000 patients.10 
In addition to the negative effects observed during a child’s active treatment stage, 
pediatric oncology patients are at risk for long-term effects of chemotherapy on dental health and 
development.  Chemotherapy is unfortunately nonselective, interfering with DNA synthesis and 
replication, RNA transcription, and cytoplasmic transport mechanisms to destroy both actively 
proliferating malignant and healthy cells.3 Younger age during treatment has been associated 
with increased abnormalities of dental development as the effects of chemotherapy are 
intensified when dental cells are rapidly multiplying.5 Formation of the primary second molar, 
the last primary tooth to erupt, is not complete until age 3. Calcification of premolars and second 
molars begins between 2-3 years of age, and crown enamel of most of the permanent dentition is 
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completed between the ages of 4 and 8. Both of these processes occur in the age range that most 
pediatric patients with leukemia are undergoing therapy. After eruption of the permanent 
dentition, root formation is not completed for 2 to 3 years.11 Agenesis, microdontia, short and 
tapering roots were observed more often in children with ALL than healthy controls; 
hypomineralization or hypomaturation of enamel and taurodontism were also noted.12 Nemeth et 
al identified root malformations as the most frequent developmental disturbance, occurring in 
over 50% of patients.13 
Increased risk for dental caries has been identified in children who are undergoing or 
have undergone treatment for cancer. Hegde et al. noted that DMFT (decayed, missing, filled 
teeth) scores were significantly higher in children with ALL as compared to healthy controls.1 
Ponce-Torres et al. noted dental caries in 82% of patients.7 Although increased DMFT was not 
observed by Yang et al, the number of untreated carious surfaces of primary teeth was increased 
in children with ALL.9 Olszewska and Mielnik-Blaszczak concluded that caries activity 
increases in children receiving antineoplastic treatment due to a significant increase in the 
quantity of cariogenic bacteria in saliva during episodes of subsequent neutropenia.14 Wogelius 
et al concluded that childhood cancer and cancer therapy were associated with increased caries 
risk, but that risk may decrease with longer follow up.15 The weighted prevalence of dental caries 
amongst survivors was highest among patients that underwent chemotherapy only as compared 
to those who underwent radiation or chemotherapy and radiation in one systematic review. It was 
suggested that this may be due to different oral care management for patients preparing for 
radiation therapy versus chemotherapy in cancer treatment centers.16 Xerostomia and levels of 
cariogenic bacteria, which are also acute-phase oral sequelae, are increased in survivors as well.5 
Research has demonstrated that formation of dental caries is a multifactorial process 
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involving aciduric and acidogenic bacteria, fermentable carbohydrate exposure, and host factors 
including teeth and saliva.17 Primary teeth are more vulnerable to rapid progression of caries due 
to thinner enamel and dentin layers and larger pulp chambers.18 The caries balance concept is 
important to prevention. The progression or reversal of carious lesions depends on eliminating 
caries-promoting factors and maximizing caries-protective factors. Food preferences and 
tolerances may shift to highly cariogenic foods during therapy. Supplements with added sugar 
may be necessary to maintain weight and liquid medications high in sucrose may be prescribed 
frequently.16 It has been well-established that patients experience decreased salivary flow rate 
secondary to salivary gland hypoplasia during chemotherapy.3 This results in decreased buffering 
capacity and promotes a caries active state in the oral cavity. The mean salivary pH of patients 
undergoing chemotherapy was 6.5 and 7.5 in control patients.1 Vomiting may also temporarily 
result in decreased intraoral pH. Compliance with oral hygiene may become more difficult and 
decrease with nausea, mucositis pain, and other complications secondary to therapy.1,19  
Therefore, optimizing caries-protective factors is of utmost importance for the pediatric oncology 
patient. Caries progression can be reduced or avoided with identification of disease indicators 
and individualized preventive practices.20  
The importance of addressing the oral health of oncology patients during treatment and as 
a survivor has been identified.2,7,8,19,21,22 Preventive practices have been shown to improve oral 
and dental outcomes for patients following chemotherapy.15  However, a survey of supportive 
health care providers found that cohesive medical and dental services were only found in 25 % of 
the respondents’ institutions. 22 Although a majority of responding institutions incorporated 
dental consultations and oral health education at diagnosis, only half provided care during 
treatment. 22 Another survey of National Cancer Institute-designated comprehensive care centers 
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found that only 19% of responding centers provided an oral assessment for all patients and 63% 
requested dental consultation for those with identified pathology or complaints. Also, 56% of 
centers did not have a dental department and only one third of patients undergoing chemotherapy 
were provided oral care and prevention education. 23 After treatment, research has also shown 
that dental utilization practices of survivors is suboptimal.24  
Multiple barriers have been suggested as challenges to oral health and prevention 
education for the oncology patient. Gaps in knowledge, reliance on tradition, inconsistent or 
absent oral assessment, diverse oral care regimens and practices, administrative and clinical 
issues, and lack of interdisciplinary collaboration have been discussed as obstacles to the 
implementation of oral health care standards. A more fundamental barrier is the lack of an 
accepted universal standard. There is little agreement amongst experts in all disciplines 
concerned with oral care of the oncology patient in regards to tools for assessment of risk, most 
appropriate oral care instructions and dental chemotherapeutic agents, clinical outcomes, and 
protocols.25 Dentists may also receive varying levels of training in the treatment of patients 
undergoing cancer therapies resulting in a limited number of dental providers comfortable and 
confident in providing oral health care and education to this unique population. 8,21 Another 
proposed barrier involves lack of financial resources for provision of dental services. 8 
The purpose of this study is to increase oral health and prevention education for pediatric 
patients with leukemia at Virginia Commonwealth University Medical Center (VCU) and to 
determine if the pediatric dental provider’s role is feasible and effective in reducing caries-
promoting factors and optimizing caries-protective factors. 
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Aim 1: Develop a protocol for interdisciplinary care of pediatric patients with leukemia that 
increases oral health and prevention education with the inclusion of a pediatric dental provider.  
Aim 2: Assess the perceived feasibility of the protocol by current providers in the Department of 
Pediatric Hematology and Oncology at VCU 
Aim 3: Assess the effectiveness of the increased oral health and prevention counseling on a 
sample of pediatric patients with leukemia.  
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Methods 
 
 
This study was approved by the Massey Cancer Center Protocol Review and Monitoring 
Committee Cancer Prevention and Control Subcommittee and the Institutional Review Board of 
VCU (IRB HM20006475), Richmond Virginia.  
Effectiveness Assessment 
 
Subject Population 
The targeted population of this study was pediatric patients ages 3 to 12 who have been 
recently diagnosed with leukemia (ALL and AML). This age range is representative of the 
pediatric patient with leukemia. Although the peak incidence occurs during ages 2 to 5, the age 
for inclusion was increased to 3 due to limited cooperation of younger patients.  Subjects were 
patients of VCU Medical Center Pediatric Hematology and Oncology Clinic.  
Research Design 
Patients treated for leukemia at VCU are currently receiving oral hygiene instruction at 
diagnosis. In this study, patients were and were be randomized into 2 groups at diagnosis: 1) 
receive current prevention education and 2) receive one-on-one prevention education and 
counseling with a pediatric dental resident.  
Standard oral health protocol at VCU involves an annual lecture given by a Pediatric 
Hematology and Oncology Attending discussing the importance of oral hygiene, current 
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standards of dental care for patients undergoing oncologic care, and dental complications of 
oncologic care.  A similar lecture is given to the pediatric dental residents. Dental residents are 
called with all new diagnoses and perform a baseline examination and identify immediate needs.  
Plans are made for children who have urgent dental needs at the beginning of therapy.  For non- 
urgent dental needs the oncology team and dental team discuss with family and make plans for 
dental care later in therapy.  The oncology team provides education about the need for a regular 
oral health routine at diagnosis.  Family are given fliers with pictograms describing proper 
brushing, use of mouth wash, and common oral complications during therapy.  Families and 
patients are also given a bottle and prescription for chlorhexidine gluconate 0.12% rinse.  
Currently the Pediatric Hematology and Oncology Attending is tracking the compliance of and 
how well her colleagues are documenting ongoing oral hygiene care.  For patients randomized 
into the second group, counseling with the hematology and oncology attending and pediatric 
dental resident will be in addition to standard protocol. Oral hygiene and care recommendations 
are reviewed at diagnosis, 16 weeks, and 32 weeks. Provided recommendations are based on 
American Academy of Pediatric Dentistry’s guideline developed after systematic literature 
review and the National Institute of Dental and Craniofacial Research’s Cancer Treatment and 
Oral Health guidelines for providers and patients.26,27 
As caries risk is dynamic, a questionnaire was administered for each patient at diagnosis 
and future points of data collection to perform caries risk assessment. Caries incidence, 
Streptococcus mutans, sobrinus, and sanguinis levels, salivary flow rate, and salivary pH was 
assessed at week one (diagnosis), week 16 or start of interim maintenance therapy whichever 
comes second, week 32 or beginning of maintenance therapy whichever is later for all patients 
enrolled in the study.  Data was collected through a clinical intraoral examination and salivary 
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sample. Data collected was used to assess the effect of increased prevention education on factors 
of importance in caries formation. 
Data was collected and stored in a password protected laptop which was kept in a locked 
file cabinet in the Department of Hematology and Oncology.  Patients were assigned a number 
from a randomization list and stored in a password- protected computer. All samples collected 
were labeled with that unique patient identifying number and no personal identifiers. 
Sepsis is not uncommon during the first nine months of leukemic therapy. Bacteria 
isolates collected at induction, interim maintenance, and beginning of maintenance were stored. 
In the event of a disseminated infection, researchers will review the bacteria isolated from the 
disseminated infection and determine its consistency with one of colonies previously collected 
during data collection.  
Exclusions of Special Populations 
 > Age 12 
 Full permanent dentition 
 Primary language is not English 
 Children in the custody of the state with no parent or legal guardian present to sign 
consent 
Sample Size 
The target sample size for the pilot study was 30 participants. Participants were 
randomized into 2 groups-fifteen in each group. A randomization list was created using a random 
number generator and each subject enrolled in the study was assigned to the corresponding 
treatment in the list. All were assigned consecutively and allocation was equal.  
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In terms of statistical power, a sample size of 30 will be able to detect a significant 
difference in the groups from baseline to follow-up with 80% power and a 0.05 significance level 
if the scores for the treatment group are better than 80% of the control group. This is based on a 
rank-sum test with n=15 per group, alpha=0.05, power=80%.28 Using a t-test, a sample size of 15 
per group will be able to detect an effect size of 1.06 (ratio of different in means to within group 
standard deviation) with 80% power and significance level of 0.05.29 Because this is a pilot 
study, we were primarily powering the difference from baseline to final follow-up. We hope to 
use data from this study to power a repeated measures analysis in a larger study.  
Enrollment Procedures 
 
Potential subjects were approached at diagnosis. The Pediatric Hematology Oncology 
fellows and attending physicians discuss enrollment with the family and patient in a private and 
quiet room in the Pediatric Hematology Oncology clinic or in the hospital. Physician, family, and 
patient discuss risks and benefits of enrollment. The letter of consent was administered and 
collected at this appointment. Assent was obtained from potential participants of appropriate age. 
Explanation of Measured Variables and Instruments 
 
Caries risk assessment 
A caries risk assessment involves discussion with parents concerning dietary habits, oral 
hygiene, and other caries-promoting and caries-protective behaviors and clinical examination of 
the pediatric patient. Information gathered on disease indicators (white spot lesions, cavitated 
lesions), risk factors (plaque, gingivitis, xerostomia), and protective factors (fluoride) is used to 
determine caries risk. Once caries risk is determined, direction was provided for implementation 
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of prevention practices. A questionnaire was administered at each point in data collection to help 
in assessment of caries risk. 
Merged ICDAS 
The concept of International Caries Detection and Assessment System (ICDAS) is based 
on the idea that a standardized, evidence-based system for detecting caries will result in 
improved diagnosis and clinical management. The Merged ICDAS format involves describing 
enamel as sound tooth (0), visual change in enamel (A), moderate decay (B), and extensive 
decay (C). Activity will be described as active lesions (+) or arrested lesions (-).30 
Salivary flow rate 
Salivary flow rate serves as an indicator of host potential for biologic repair. Stimulated salivary 
flow rate was measured utilizing pre-weighed cotton rolls. Patients were asked to saturate a 
cotton roll over one minute by chewing. Tubes were centrifuged for two minutes at 1,000 X g to 
collect saliva. Saliva was transferred to dose cup with micropipette. Dose cups were weighed 
prior to and after data collection. The change in weight in grams were converted to mL of saliva 
collected. Density of saliva is approximately 1g/mL. The obtained volume was divided by 
collection time to provide salivary flow rate in mL/min. 3  
Salivary pH 
Salivary pH was measured from saliva sample collected for salivary flow rate after flow rate was 
determined with 5.5-8.0 litmus paper. Fifty microliters of saliva were measured with pipette. 
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Bacteria known to be involved in the caries process are aciduric and acidogenic. Therefore, 
lower pH may indicate higher presence of cariogenic bacteria. 
Streptococcus mutans, streptococcus sobrinus, and streptococcus sanguinis 
Streptococcus mutans and sobrinus are two bacterial species that represent bacterial 
challenge and serve as indicators of a caries-promoting environment. Streptococcus sanguinis is 
a health-associated commensal. Samples were collected from the buccal surface of most 
posterior maxillary right tooth and maxillary left tooth at each point of data collection. Samples 
from most posterior maxillary right tooth were analyzed with qPCR to quantify levels of 
Streptococcus mutans, sobrinus, and sanguinis. Samples from the most posterior maxillary left 
tooth were stored at -70 degrees Celsius for comparison to bacteria isolated in the event of 
disseminated infection. All specimens collected were analyzed in the Phillips Institute for Oral 
Health Research at VCU.  
Feasibility Assessment 
 
Members of the VCU Pediatric Hematology Oncology Clinic were presented details of 
the aforementioned protocol and given a questionnaire to assess their perceptions and get 
feedback (Appendix 1). The items addressed the potential benefit to the patient and the burden 
on the providers and allowed for respondents to indicate any potential barriers for implementing 
the protocol.  
Data Analysis 
Results from the feasibility questionnaire were described using summary statistics 
(counts and percentages). For the effectiveness portion of the study, changes in continuous, 
normally distributed measures from diagnosis to follow-up visits were assessed using t-tests. 
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Changes from baseline to follow-up in caries risk (and any other non-normally distributed 
measures) were assessed using a nonparametric rank-sum test. If possible, repeated measures 
ANOVA will be used to account for all three time points (baseline, 16 weeks, 32 weeks) but 
given the limited sample size and nature of this pilot study, our primary analyses will be on the 
change from baseline to each follow-up.  
. 
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Results 
 
 
Feasibility Results 
 
A total of 13 of the 15 included providers completed the questionnaire (response rate: 
86.67%). Prior to completing the questionnaire, respondents received education of the proposed 
role of the pediatric dentist, inclusion criteria for the study, and supplemental education 
materials. Respondents were asked to indicate their agreement with statements regarding the 
feasibility, importance, and implementation of the proposed protocol using a scale from Strong 
Disagree to Strongly Agree (scored as -2 through 2 by 1). For the feasibility of the protocol, the 
average response was 1.4 (between Agree and Strongly Agree) and the responses ranged from 
Neutral (n=1) to Strongly Agree (n=6). The importance of addressing oral health during 
oncology treatment was rated on average 1.7 (between Agree and Strongly Agree), with 10 
respondents strongly agreeing and 3 agreeing. When asked if the addition of the protocol would 
be a valuable addition to the patients’ care, 8 respondents strongly agreed and 5 agreed (average 
agreement: 1.6). Results are given in Table 1. 
A set of 7 possible strengths were presented and respondents were asked to indicate which they 
felt were strengths of the proposed protocol. The complete list is given in Table 2/Figure 1. All 
respondents indicated that the protocol addresses a known problem for the patients (n=13, 
100%). Other highly indicated strengths were increasing parent and patient knowledge (n=11, 
85%) and the interdisciplinary addition of the pediatric dentist to the patient care team (n=11, 
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85%). Roughly 75% felt the protocol would be simple to implement (n=10, 77%) and would 
improve patient quality of life (n=10, 77%). Sixty-two percent (8 of 13) felt there would be low 
burden on the current providers to implement. 
A set of 6 possible weaknesses were presented and respondents were asked to indicate 
which they felt were weaknesses of the proposed protocol. The complete list is given in Table 3. 
Over half of the respondents indicated that they would need more training before full 
implementation of the protocol (n=7, 54%). No one indicated the burden it would place on 
current providers or that it would have a low impact on the patients as possible weaknesses.  
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Discussion 
 
 
As leukemia is the most common pediatric malignancy and oral sequelae are noted during 
therapy and in survivors, pediatric dentists should serve an important role in multidisciplinary care 
of these children. Acute and long-term oral sequelae are well-documented in children receiving 
cancer therapies, including dental caries. Pediatric patients with leukemia are immunosuppressed; 
therefore, prevention of the start or progression of oral disease is important in reducing 
complications during treatment. Increased role of the pediatric dentist in the oral health and 
prevention education and care of patients with leukemia could also play an important part in 
decreasing risk for caries in patients undergoing cancer therapy and survivors. Although it is more 
difficult to eliminate or minimize risk for some acute and long-term sequelae of cancer therapy, 
dental caries is a preventable and common effect of therapy that may be addressed by increased 
role of pediatric dental provider as a member of the oncology care team. 
There is minimal prospective or randomized research regarding the dental provider’s 
involvement in care of survivors of childhood cancer.31 
Many of the previously suggested barriers are addressed in the proposed protocol, 
including gaps in knowledge, reliance on tradition, diversity in oral care regimens and practices, 
inconsistency of oral assessment, administrative and clinical issues, and lack of interdisciplinary 
collaboration. One hundred percent of responding providers in the Department of Hematology 
and Oncology were in agreement that the proposed protocol addressed a known problem for their 
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patients. None of the providers indicated they believed implementation would have a low impact 
on their patients. Gaps in knowledge, especially of the patient and parent, would be lessened with 
one-on-one prevention and supportive oral health education with the pediatric dental provider at 
several points during treatment. Eighty-five percent of responding physicians identified 
increased parent and patient knowledge as a strength of the protocol. The family would also have 
an established relationship with a dental provider knowledgeable of the patient’s unique special 
healthcare needs. The proposed protocol provides preventive and supportive oral care 
recommendations based on a systematic review of most recent oncology literature and presented 
as a guideline by the American Academy of Pediatric Dentistry. This minimizes reliance on 
tradition and proposes an alternative to diverse oral care regimens and practices previously 
noted. The protocol provides a schedule for follow up oral examination and review of preventive 
and supportive recommendations and self-management goals which provides consistency of oral 
assessment. 
Administrative and clinical issues have also been mentioned as a barrier, particularly 
limited time of the nurse or physician to address oral health amongst other responsibilities.25 
Delegation of responsibilities to the pediatric dental provider would lessen the burden on current 
members of the pediatric oncology care team and ensure more dedicated attention by one 
provider to oral preventive and supportive care. None of the responding providers indicated that 
a weakness of the proposed protocol was burden on the current provider. While 77% and 62% 
indicated that a strength was simplicity of implementation and low burden on the current 
provider respectively, this may be higher if there was a dental department and designated 
provider within the cancer center. At VCU, pediatric dentistry serves as a consulting service so 
current providers are responsible for notifying pediatric dentistry of new diagnoses and 
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scheduling consultations. This may also explain why 23% of respondents identified time 
required for implementation as a weakness. The 53% indicating that more training would be 
necessary in order to implement is likely due to the assumption of assumed responsibility of 
education, oral assessment, and salivary analysis in the absence of the pediatric dental provider. 
Addition of the pediatric dentist addresses the recommended standard of interdisciplinary care of 
pediatric oncology patients; 85% of respondents indicated that this was a strength of the 
proposed protocol.  
Limitations of this study are important to note. Feasibility agreement of providers in our 
study may not be generalizable to other institutions. Providers already have an established, yet 
limited relationship with pediatric dentistry and are thus more familiar with the idea of inclusion 
of the pediatric dentist in multidisciplinary care of their patients. It is not uncommon for 
physicians and nurses provide preventive and supportive oral health care.  In a survey of 
National Cancer Institute (NCI)- designated comprehensive cancer centers, 32% of responding 
centers stated that physicians and nurses managed oral complications.23 This may represent an 
optimistic view as centers that did not respond may have had less awareness of importance and 
established support of oral health care during cancer therapy. In another survey of current 
practice, nurses were responsible for oral health in 23% of responding cancer care centers.32 It 
may be more difficult to implement the pediatric dentist’s role in centers without established 
dental presence, which may be why NCI recommends that all cancer treatment centers have an 
established dental department.23 
If clinical effectiveness is demonstrated, this proposed protocol involving the pediatric 
dentist as a member of the pediatric oncology patient’s care team throughout therapy may 
contribute to a universal evidence-based guidelines and recommendations for oral health and 
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prevention care. Oncology literature supports that the prevention and effective management of 
oral and dental complications during therapy may improve oral function and quality of life and 
decrease morbidity and cost of care.22 Seventy-seven percent of responding providers in the 
Department of Pediatric Hematology and Oncology indicated the potential of the protocol to 
improve patient quality of life. It may also provide support in the realization of the National 
Cancer Institute’s recommendation that all cancer treatment centers have an established dental 
department.23  
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Conclusion 
 
 
The addition of the pediatric dentist to the pediatric oncology care team is warranted and 
feasible.  
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Tables 
 
 
Table 1. Average Agreement with Statements Regarding Feasibility, Importance, and Value 
 Average            SD
It is feasible to incorporate this protocol into patient care. 1.38 0.65
It is important to address oral health during oncology 
treatment. 1.77 0.44
Implementing this protocol would be a valuable addition to our 
patients' care. 1.62 0.51
*2=Strongly Agree, -2=Strongly Disagree 
 
Table 2. Strengths of Proposed Protocol as Indicated by Respondents 
Strengths n % 
Addresses a known problem for the patients 13 100% 
Simple to implement 10 77% 
Potential to improve patient quality of life 10 77% 
Increases parent and patient knowledge 11 85% 
Addition of pediatric dentist to the patient care team 11 85% 
Low burden on current providers 8 62% 
Other 2 15% 
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Table 3.Weaknesses of Proposed Protocol as Indicated by Respondents 
Weaknesses n % 
Burden on current providers 0 0% 
Time required for implementation 3 23% 
Low impact on patient 0 0% 
Quality of distributed patient education materials 2 15% 
More training would be necessary in order to 
implement 7 54% 
Other 2 15% 
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Figure 1. Strengths of Proposed Protocol as Indicated by Respondents 
 
 
Figure 2.Weaknesses of Proposed Protocol as Indicated by Respondents 
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Examiner Signature: _______________________________________  Date: ______________ 
CARIES CHARTING
DATE OF VISIT
_____/ _____/_____
SUBJECT INITIALS  
_____ _____ _____ 
Completed by: _______
_____ _____ _____ 
?????? ??????________?
SUBJECT NUMBER 
Surface Condition
0 not restored or sealed
1 sealant (partial)
2 sealant (full)
3 tooth colored restoration
4 amalgam
5 stainless steel crown
7 lost or broken restoration
8 temporary restoration
Caries Code
0 sound enamel
A visual changes in enamel
B moderate decay
C extensive decay 
Activity
+ active lesion
- arrested lesion
Missing Codes
97 tooth missing due to caries
98 tooth missing for other reasons
99 tooth unerupted
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Page 1 of 1Pediatric Hematology Oncology Questionnaire 
Please complete the survey below.
Thank you!
It is feasible to incorporate this protocol into patient care. 
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
It is important to address oral health during oncology treatment.
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Implementing this protocol would be a valuable addition to our patients' care.
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Please select any of the following that you feel are strengths of this proposed protocol (Check all that apply). 
Addresses a known problem for the patients
Simple to implement
Potential to improve patient quality of life
Increases parent and patient knowledge
Addition of pediatric dentist to the patient care team
Low burden on current providers
Other
Please specify any other strengths or suggestions: 
 
__________________________________
Please select any of the following that you feel are areas for improvement with the proposed protocol (Check all that
apply).
Burden on current providers
Time required for implementation
Low impact on patient
Quality of distributed patient education materials
More training would be necessary in order to implement
Other
Please specify any other areas for improvement or suggestions: 
 
__________________________________
35
